Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Verinurad (RDEA3170) (RDEA3170) is an organic anion transporter URAT1 (SLC22A12) inhibitor for the treatment of gout and hyperuricemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 89.00 | |
25 mg | In stock | $ 143.00 | |
50 mg | In stock | $ 198.00 | |
100 mg | In stock | $ 297.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 70.00 |
Description | Verinurad (RDEA3170) (RDEA3170) is an organic anion transporter URAT1 (SLC22A12) inhibitor for the treatment of gout and hyperuricemia. |
Targets&IC50 | URAT1 transporter:25 nM |
Synonyms | RDEA3170 |
Molecular Weight | 348.42 |
Formula | C20H16N2O2S |
CAS No. | 1352792-74-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (129.15 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Verinurad 1352792-74-5 Membrane transporter/Ion channel OAT Urate transporter 1 Inhibitor SLC22A12 inhibit URAT1 RDEA3170 RDEA 3170 RDEA-3170 inhibitor